Li Dean Y
SEC insider (Form 3/4/5 filer). CIK 0001837016. Director at RECURSION PHARMACEUTICALS, INC. (RXRX) and 1 other issuer. 22 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in SALT LAKE CITY, UT.
Companies Li Dean Y has filed insider reports for
- RECURSION PHARMACEUTICALS, INC. (RXRX): Director
- Merck & Co., Inc. (MRK): Officer, Executive VP & President, MRL
Li Dean Y
CIK: 0001837016
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Oct 1, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect3.4K shares- - Jul 1, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect3.7K shares- - Jun 17, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect88.4K shares- - May 5, 2026MRK
Merck & Co., Inc.
AwardDirectStock Option (Right to Buy)
58.2K shares- - May 5, 2026MRK
Merck & Co., Inc.
AwardDirectRestricted Stock Unit
19.9K shares- - Apr 29, 2026MRK
Merck & Co., Inc.
Tax PaymentDirect2.3K shares at avg. $110.03$256K - Apr 29, 2026MRK
Merck & Co., Inc.
ExerciseDirect4.7K shares at avg. $110.03$520K - Apr 1, 2026RXRX
RECURSION PHARMACEUTICALS, INC.
AwardDirect3.3K shares- - Feb 10, 2026MRK
Merck & Co., Inc.
SaleDirect10.2K shares at avg. $117.52$1.2M - Feb 4, 2026MRK
Merck & Co., Inc.
SaleDirect15.1K shares at avg. $118.77$1.8M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  RXRX RECURSION PHARMACEUTICALS, INC. | Award | 3,378 | - | $0 | Direct |
| Jul 1, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 3,747 | - | $0 | Direct |
| Jun 17, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 88,424 | - | $0 | Direct |
| May 5, 2026 |  MRK Merck & Co., Inc. | Award Stock Option (Right to Buy) | 58,207 | - | - | Direct |
| May 5, 2026 | MRK Merck & Co., Inc. | Award Restricted Stock Unit | 19,885 | - | - | Direct |
| Apr 29, 2026 | MRK Merck & Co., Inc. | Tax Payment | 2,326 | $110.03 | $255,930 | Direct |
| Apr 29, 2026 | MRK Merck & Co., Inc. | Exercise | 4,722 | $110.03 | $519,562 | Direct |
| Apr 1, 2026 | RXRX RECURSION PHARMACEUTICALS, INC. | Award | 3,268 | - | $0 | Direct |
| Feb 10, 2026 | MRK Merck & Co., Inc. | Sale | 10,235 | $117.52 | $1,202,844 | Direct |
| Feb 4, 2026 | MRK Merck & Co., Inc. | Sale | 15,087 | $118.77 | $1,791,824 | Direct |
1-10 of 22 transactions